Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1975 May;31(5):581–584. doi: 10.1038/bjc.1975.99

Hepatitis Bs antigen and liver cancer: A population based study in Kenya.

A F Bagshawe, D M Gacengi, C H Cameron, J Dorman, D S Dane
PMCID: PMC2009441  PMID: 1156531

Abstract

Peers and Linsell (1973) demonstrated a significant association between the incidence of primary liver cancer and ingested aflatoxin in a study in the Muranga district of Kenya. A study of hepatitis B antigen in the same district showed no significant differences between the low altitude area, with a relatively high incidence of primary liver cancer, and the high altitude area with a lower incidence of the tumour. Current evidence is more in favour of aflatoxin playing an important role in the aetiology of primary liver cancer but hepatitis B antigen may play an ancillary role.

Full text

PDF
581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Keen P., Martin P. Is aflatoxin carcinogenic in man? The evidence in Swaziland. Trop Geogr Med. 1971 Mar;23(1):44–53. [PubMed] [Google Scholar]
  2. Parker A. M., Muiruri K. L., Preston J. K. Hepatitis-associated antigen in blood donors in Kenya. East Afr Med J. 1971 Sep;48(9):470–475. [PubMed] [Google Scholar]
  3. Peers F. G., Linsell C. A. Dietary aflatoxins and liver cancer--a population based study in Kenya. Br J Cancer. 1973 Jun;27(6):473–484. doi: 10.1038/bjc.1973.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Prince A. M. Role of serum hepatitis virus in chronic liver disease. Gastroenterology. 1971 May;60(5):913–921. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES